1. Market Research
  2. > Pathology
21 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Medical Laboratory Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Global Version

  • $ 5995
  • April 2017
  • 263 pages

lymphoma, and transplant.

  • Biotech Diagnostics
  • Laboratory
  • Lymphoma
  • Molecular Diagnostics
  • United States

In Vitro Diagnostic Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Global Version

  • $ 5995
  • April 2017
  • 263 pages

lymphoma, and transplant.

  • Biotech Diagnostics
  • Laboratory
  • Lymphoma
  • Molecular Diagnostics
  • United States

Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services. Strategies & Trends. Volume & Price Forecasts by Laboratory Department. 2017 to 2022 - Global Version

  • $ 5995
  • April 2017
  • 263 pages

lymphoma, and transplant.

  • Biotech Diagnostics
  • Laboratory
  • Lymphoma
  • Molecular Diagnostics
  • United States

Molecular Diagnostics: Infectious Disease, Genetic and Oncology Testing Market Size, Strategies and Forecasts 2016 to 2019 Global Version

  • $ 4995
  • June 2016
  • 239 pages

Sequenta, meantime, offers its own clinical test, ClonoSight, which uses proprietary technology to target immune cells and measure MRD in leukemia and lymphoma patients.

  • Biotech Diagnostics
  • Genetic Testing
  • Infectious Disease
  • Lymphoma
  • United States

Liquid Biopsy Markets by Lung, Breast, Colorectal, Prostate and Other. 2017-2020 Including Screening Market Potential Size with Executive and Consultant Guides

  • $ 5495
  • March 2017
  • 251 pages

In malignancies of blood cells (leukemia and ##. ## BIOPSY SITES ##. ## THE SITUATION TODAY - BIOPSY ANALYSIS Gastrointestinal tract lymphoma) a bone marrow biopsy is used in staging the disease.

  • Cancer
  • Genetic Testing
  • Lung Cancer
  • Lymphoma
  • United States

Circulating Tumor Cell, Cell Free DNA and Exosome/Microvesicle Cancer Diagnostics by Lung, Breast, Colorectal, Prostate and Other. 2017-2020

  • $ 5495
  • March 2017
  • 251 pages

In malignancies of blood cells (leukemia and ##. ## BIOPSY SITES ##. ## THE SITUATION TODAY - BIOPSY ANALYSIS Gastrointestinal tract lymphoma) a bone marrow biopsy is used in staging the disease.

  • Cancer
  • Genetic Testing
  • Lung Cancer
  • Lymphoma
  • United States

Medical Laboratory Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Europe Version

  • $ 4995
  • April 2017
  • 216 pages

lymphoma, and transplant.

  • Biotech Diagnostics
  • Laboratory
  • Lymphoma
  • Molecular Diagnostics
  • United States

In Vitro Diagnostic Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Europe Version

  • $ 4995
  • April 2017
  • 216 pages

lymphoma, and transplant.

  • Biotech Diagnostics
  • Laboratory
  • Lymphoma
  • Molecular Diagnostics
  • United States

Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services. Strategies & Trends. Volume & Price Forecasts by Laboratory Department. 2017 to 2022 - Europe Version

  • $ 4995
  • April 2017
  • 216 pages

lymphoma, and transplant.

  • Biotech Diagnostics
  • Laboratory
  • Lymphoma
  • Molecular Diagnostics
  • United States

Molecular Diagnostics: Infectious Disease, Genetic and Oncology Testing Market Size, Strategies and Forecasts 2016 to 2019 North America Version

  • $ 4495
  • June 2016
  • 266 pages

Sequenta, meantime, offers its own clinical test, ClonoSight, which uses proprietary technology to target immune cells and measure MRD in leukemia and lymphoma patients.

  • Genomics
  • Laboratory
  • Lymphoma
  • Molecular Diagnostics
  • United States

Molecular Diagnostics: Infectious Disease, Genetic and Oncology Testing Market Size, Strategies and Forecasts 2016 to 2019 Latin America, Africa & Mideast

  • $ 4495
  • June 2016
  • 195 pages

Sequenta, meantime, offers its own clinical test, ClonoSight, which uses proprietary technology to target immune cells and measure MRD in leukemia and lymphoma patients.

  • Genetic Testing
  • Laboratory
  • Lymphoma
  • Molecular Diagnostics
  • United States

Molecular Diagnostics: Infectious Disease, Genetic and Oncology Testing Market Size, Strategies and Forecasts 2016 to 2019 Asia Pacific Version

  • $ 4495
  • June 2016
  • 203 pages

Sequenta, meantime, offers its own clinical test, ClonoSight, which uses proprietary technology to target immune cells and measure MRD in leukemia and lymphoma patients.

  • Genetic Testing
  • Laboratory
  • Lymphoma
  • Molecular Diagnostics
  • United States
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on